Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Illumina’s new BeadChip lowers the cost of DNA and RNA research

Illumina : 21 April, 2008  (New Product)
Illumina has introduced the HumanHT-12 BeadChip, a twelve sample product designed to accelerate whole genome expression and expression-based Quantitative Trait Loci (eQTL) studies.
The HumanHT-12 BeadChip includes over 48,000 probes per sample and is priced at $75, supporting a total cost of $100 per sample including labelling reagents. Illumina expects to commence shipment of this new product in the second quarter 2008.

'The HumanHT-12 BeadChip is a powerful new product that will enable high-throughput whole-genome expression and eQTL analysis at exceptional price points. Along with the HumanWG-6, which offers the industry's highest quality whole-genome expression data, the HumanHT-12 will provide gene expression researchers with the most flexible and cost effective screening tool,' said Tristan Orpin, Illumina's senior vice president of commercial operations.

'Additionally, the HumanHT-12 will allow researchers to enhance their genomics studies by the economical addition of eQTL data. The ability to cost effectively complement large-scale genotyping studies with gene expression profiles will allow researchers to gain additional important insights into the relationship between genotypes and phenotypic profiles.'

The introduction of the HumanHT-12 BeadChip further enhances Illumina's suite of gene expression products, which includes sequencing-based assays for discovery and typing of transcripts, alternative splice forms, and small and microRNA's, and array-based assays for rapid and cost effective profiling of expression in human, rat, and mouse.

The new HumanHT-12 BeadChip provides the same content as that of the HumanWG-6 BeadChip, and researchers using the HumanHT-12 can expect to measure data from greater than 99.99 percent of the probe sets for each sample. To accelerate the use of the HumanHT-12 as a component of genotyping studies, Illumina will offer special pricing to customers ordering both its Infinium Genotyping BeadChips and its HumanHT-12 BeadChips.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo